KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Treasury Shares (2021 - 2025)

Aurinia Pharmaceuticals' Treasury Shares history spans 5 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 52.77% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $12.2 million, up 52.77%, while the annual FY2025 figure was $12.2 million, 52.77% up from the prior year.
  • Treasury Shares reached $12.2 million in Q4 2025 per AUPH's latest filing, roughly flat from $12.2 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $14.8 million in Q2 2021 to a low of $347000.0 in Q4 2021.
  • Average Treasury Shares over 5 years is $6.9 million, with a median of $7.8 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: crashed 86.78% in 2022, then skyrocketed 918.18% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $347000.0 in 2021, then surged by 470.61% to $2.0 million in 2022, then skyrocketed by 294.29% to $7.8 million in 2023, then rose by 2.29% to $8.0 million in 2024, then skyrocketed by 52.77% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Treasury Shares are $12.2 million (Q4 2025), $12.2 million (Q3 2025), and $11.2 million (Q2 2025).